Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...
Những tác giả chính: | Elliott, J, Lockwood, C, Hale, G, Waldmann, H |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
1998
|
Những quyển sách tương tự
-
Monoclonal-antibody therapy in systemic vasculitis.
Bằng: Mathieson, P, et al.
Được phát hành: (1990) -
MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
Bằng: Mathieson, P, et al.
Được phát hành: (1990) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
Bằng: Lockwood, C, et al.
Được phát hành: (1993) -
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Bằng: Lockwood, C, et al.
Được phát hành: (1993) -
MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
Bằng: Isaacs, J, et al.
Được phát hành: (1993)